JFrog Ltd. FROG 深 滬
等待開盤 02-07 09:30:00 美东时间
47.99
+0.340
+0.71%
華盛通- 最 高49.77
- 今 開48.72
- 成交量 347.73万股
- 最 低 45.73
- 昨 收 47.65
- 總市值 56.78亿
- 52周最高 70.4299
- 市盈率 靜 --
- 換手率 2.94%
- 52周最低 27.00
- 委 比 -92.26%
- 總股本 1.18亿
- 歷史最高 95.20
- 量 比 1.15
- 振 幅 8.48%
- 歷史最低 16.356
- 每 手 1
- 風險率 10.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Snowflake, MongoDB, Datadog, JFrog likely to rise after 'SaaSpocalypse' ends: BofA
Snowflake (SNOW), MongoDB (MDB), Datadog (DDOG), and JFrog (FROG) are likely to be among the first enterprise software stocks to rebound after the “SaaSpocalypse” ends, Bank of America said. Snowflake...
02-06 22:07
Extended enterprise software selloff hits seat-based business models hardest: Truist
The enterprise software sector has experienced extreme volatility due to continued concerns over artificial intelligence disruption, and Truist Securities noted that companies with seat-based business...
02-06 00:45
美股大行评级 | 泰瑞达、Lumentum、哈贝尔、Enphase能源、西部数据获多家机构上调目标价；PayPal 、恩智浦、墨式烧烤遭多家机构下调目标价
今日重点评级关注：韦德布什：维持Replimune Group"跑赢大市"评级，目标价从18美元升至19美元；巴克莱：维持CytomX Therapeutics"超配"评级，目标价从8美元升至10美元
02-05 11:28
Cantor Fitzgerald Reiterates Overweight on JFrog, Maintains $80 Price Target
Cantor Fitzgerald analyst Jonathan Ruykhaver reiterates JFrog (NASDAQ:FROG) with a Overweight and maintains $80 price target.
02-05 00:05
JFrog CTO Yoav Landman Reports Sale of Common Shares
JFrog CTO Yoav Landman Reports Sale of Common Shares Yoav Landman, Chief Technology Officer and Director of JFrog Ltd., has reported a disposal of common shares of JFrog Ltd. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT)
01-22 05:15
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Barclays Maintains Overweight on JFrog, Raises Price Target to $70
Barclays analyst Ryan Macwilliams maintains JFrog (NASDAQ:FROG) with a Overweight and raises the price target from $67 to $70.
01-13 04:03
美股大行评级 | 瑞银上调美光科技目标价从300美元升至400美元；Freedom上调百度目标价从120美元升至160美元
今日重点评级关注：Needham：维持Vaxcyte"买入"评级，目标价从90美元升至110美元；Citizens: 维持LGI Homes"跑赢大市"评级，目标价从85美元升至95美元
01-08 18:33
Oppenheimer’s best small and mid-cap ideas for 2026
Oppenheimer Research released a list of its best ideas for small-caps and mid-caps in the new year. Analysts said that, absent the traditional warning signs that have historically preceded market down...
01-07 00:59
美股大行评级 | 潜在涨幅36.7%！LMRI获多家大行首予超配评级； 瑞银下调甲骨文目标价从325美元至280美元
今日重点评级关注：HC Wainwright & Co.：维持Assertio Holdings"买入"评级，目标价从3美元升至35美元；HC Wainwright & Co.：维持万达生物制药"买入"评级，目标价从20美元升至22美元
01-06 17:52
